Journal
JOURNAL OF IMMUNOLOGY
Volume 197, Issue 11, Pages 4187-4192Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1601476
Keywords
-
Categories
Funding
- National Institutes of Health [HL124283, AR064418, AI115534]
- Nipponham Foundation for the Future of Food
Ask authors/readers for more resources
IgE is the least abundant Ig isotype, yet it plays a critical role in allergic reactions and host protection from helminth infection. Although IgE was discovered 50 years ago, the ultimate evidence for its role in human allergic diseases was obtained by the efficacy of anti-IgE therapy in many clinical trials on asthma and other allergic diseases. Beginning from the discovery of IgE 50 y ago, followed by studies of IgE receptors and activation mechanisms, this review provides a historic perspective of allergy research that has led to the development of anti-IgE therapy and other strategies targeting IgE and its receptors. Current IgE studies toward future precision medicine are also reviewed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available